Macro-efforts for the micro-elimination of hepatitis C targeting people who inject drugs

被引：3
作者：
Lee, Shui-Shan [1 ]
Crofts, Nick [2 ]
Hung, Chien-Ching [3 ,4 ,5 ]
机构：
[1] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Peoples R China
[2] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia
[3] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[4] Natl Taiwan Univ, Coll Med, Taipei, Taiwan
[5] Natl Taiwan Univ, Coll Med, Dept Trop Med & Parasitol, Taipei, Taiwan
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2019年 / 85卷
关键词：
CARE; PREVALENCE; ACCESS; HIV; HCV;
D O I：
10.1016/j.ijid.2019.06.003
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：141 / 142
页数：2
相关论文
共 21 条
[1]  
Bourgeois S, 2019, ACTA GASTRO-ENT BELG, V82, P43
[2]   Uptake of direct acting antiviral therapies for the treatment of hepatitis C virus among people who inject drugs in a universal health-care system [J].
Butler, Kerryn ;
Larney, Sarah ;
Day, Carolyn A. ;
Burns, Lucinda .
DRUG AND ALCOHOL REVIEW, 2019, 38 (03) :264-269
[3]   Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs [J].
Day, Emma ;
Broder, Tina ;
Bruneau, Julie ;
Cruse, Sally ;
Dickie, Melisa ;
Fish, Suzanne ;
Grillon, Celine ;
Luhmann, Niklas ;
Mason, Kate ;
McLean, Elizabeth ;
Trooskin, Stacey ;
Treloar, Carla ;
Grebely, Jason .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2019, 66 :87-93
[4]   Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review [J].
Degenhardt, Louisa ;
Peacock, Amy ;
Colledge, Samantha ;
Leung, Janni ;
Grebely, Jason ;
Vickerman, Peter ;
Stone, Jack ;
Cunningham, Evan B. ;
Trickey, Adam ;
Dumchev, Kostyantyn ;
Lynskey, Michael ;
Griffiths, Paul ;
Mattick, Richard P. ;
Hickman, Matthew ;
Larney, Sarah .
LANCET GLOBAL HEALTH, 2017, 5 (12) :E1192-E1207
[5]  
Dillon John F, 2016, Hepatol Med Policy, V1, P2, DOI 10.1186/s41124-016-0011-y
[6]   Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore [J].
Falade-Nwulia, Oluwaseun ;
Irvin, Risha ;
Merkow, Alana ;
Sulkowski, Mark ;
Niculescu, Alexander ;
Olsen, Yngvild ;
Stoller, Kenneth ;
Thomas, David L. ;
Latkin, Carl ;
Mehta, Shruti H. .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2019, 100 :45-51
[7]   Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs [J].
Grebely, Jason ;
Larney, Sarah ;
Peacock, Amy ;
Colledge, Samantha ;
Leung, Janni ;
Hickman, Matthew ;
Vickerman, Peter ;
Blach, Sarah ;
Cunningham, Evan B. ;
Dumchev, Kostyantyn ;
Lynskey, Michael ;
Stone, Jack ;
Trickey, Adam ;
Razavi, Homie ;
Mattick, Richard P. ;
Farrell, Michael ;
Dore, Gregory J. ;
Degenhardt, Louisa .
ADDICTION, 2019, 114 (01) :150-166
[8]   A Stepwise Approach to a National Hepatitis C Screening Strategy in Malaysia to Meet the WHO 2030 Targets: Proposed Strategy, Coverage, and Costs [J].
Hiebert, Lindsey ;
Hecht, Robert ;
Soe-Lin, Shan ;
Mohamed, Rosmawati ;
Shabaruddin, Fatiha H. ;
Mansor, Syed Mukhtar Syed ;
Dahlui, Maznah ;
Azzeri, Amirah ;
McDonald, Scott A. .
VALUE IN HEALTH REGIONAL ISSUES, 2019, 18 :112-120
[9]   The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations [J].
Lazarus, Jeffrey V. ;
Safreed-Harmon, Kelly ;
Thursz, Mark R. ;
Dillon, John F. ;
El-Sayed, Manal H. ;
Elsharkawy, Ahmed M. ;
Hatzakis, Angelos ;
Jadoul, Michel ;
Prestileo, Tullio ;
Razavi, Homie ;
Rockstroh, Juergen K. ;
Wiktor, Stefan Z. ;
Colombo, Massimo .
SEMINARS IN LIVER DISEASE, 2018, 38 (03) :181-192
[10]   Micro-elimination - A path to global elimination of hepatitis C [J].
Lazarus, Jeffrey V. ;
Wiktor, Stefan ;
Colombo, Massimo ;
Thursz, Mark .
JOURNAL OF HEPATOLOGY, 2017, 67 (04) :665-666
123